PHAT icon

Phathom Pharmaceuticals

137 hedge funds and large institutions have $401M invested in Phathom Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
-7
Holders Change %
-4.86%
% of All Funds
1.86%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.08%
New
25
Increased
47
Reduced
36
Closed
31
Calls
$915K
Puts
$688K
Net Calls
+$227K
Net Calls Change
+$4.97M
Name Holding Trade Value Shares
Change
Shares
Change %
CM
151
Capula Management
Cayman Islands
-$131K -16,083 Closed
Canada Pension Plan Investment Board
152
Canada Pension Plan Investment Board
Ontario, Canada
-$125K -15,400 Closed
N
153
Numerai
California
-$124K -15,264 Closed
GCP
154
GSA Capital Partners
United Kingdom
-$123K -15,173 Closed
BCM
155
Bayesian Capital Management
New York
-$121K -14,900 Closed
SWA
156
Stratos Wealth Advisors
Ohio
-$109K -13,438 Closed
VF
157
Virtu Financial
New York
-$109K -13,424 Closed
PA
158
Profund Advisors
Maryland
-$108K -13,310 Closed
VI
159
Versor Investments
New York
-$101K -12,400 Closed
Rafferty Asset Management
160
Rafferty Asset Management
New York
-$90.2K -11,113 Closed
KA
161
Klingman & Associates
New York
-$85.4K -10,517 Closed
PD
162
Point72 (DIFC)
United Arab Emirates
-$15.8K -1,951 Closed
RS
163
R Squared
Hong Kong
-$8.62K -1,061 Closed
GP
164
Greenline Partners
New York
-$4.06K -500 Closed
BL
165
BFSG LLC
California
-$2.44K -300 Closed
RAM
166
Riggs Asset Management
Pennsylvania
-$552 -69 Closed
ACM
167
Aster Capital Management
United Arab Emirates
-$122 -15 Closed